Clopidogrel News and Research

RSS
Clopidogrel is an oral antiplatelet agent (thienopyridine class) to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.
Clot busting drug combo reduces risk of major strokes in high risk patients

Clot busting drug combo reduces risk of major strokes in high risk patients

Drug combination may prevent secondary stroke in certain patients, study shows

Drug combination may prevent secondary stroke in certain patients, study shows

Taking clot-preventing drug with aspirin may lower risk of major stroke, finds study

Taking clot-preventing drug with aspirin may lower risk of major stroke, finds study

Genetic testing could help guide blood-thinner treatment after stent placement

Genetic testing could help guide blood-thinner treatment after stent placement

Patients given six-month dual antiplatelet therapy have increased heart attack risk

Patients given six-month dual antiplatelet therapy have increased heart attack risk

Two anticlotting medicines better at reducing bleeding risk than triple therapy

Two anticlotting medicines better at reducing bleeding risk than triple therapy

New ESC Focused Update provides recommendations on DAPT in patients with coronary artery disease

New ESC Focused Update provides recommendations on DAPT in patients with coronary artery disease

Researchers develop new scoring method to predict bleeding risk after stroke

Researchers develop new scoring method to predict bleeding risk after stroke

Low-risk atrial fibrillation patients fare better without antithrombotic therapy, study finds

Low-risk atrial fibrillation patients fare better without antithrombotic therapy, study finds

Genetic testing at UMMC helps doctors identify effective medication for heart stent patients

Genetic testing at UMMC helps doctors identify effective medication for heart stent patients

Euro Heart Index 2016: France ranks 1st in heart care

Euro Heart Index 2016: France ranks 1st in heart care

New guidelines recommend use of antiplatelet therapy and exercise program for treatment of PAD

New guidelines recommend use of antiplatelet therapy and exercise program for treatment of PAD

NCDR provides data to study appropriate use of oral anticoagulant therapy

NCDR provides data to study appropriate use of oral anticoagulant therapy

Study shows non-inferiority of short-term dual antiplatelet therapy in patients with DES placement

Study shows non-inferiority of short-term dual antiplatelet therapy in patients with DES placement

New study to examine genomics of anti-platelet therapy after coronary interventions

New study to examine genomics of anti-platelet therapy after coronary interventions

'Novel' analysis addresses antiplatelet benefits in real-world CHD patients

'Novel' analysis addresses antiplatelet benefits in real-world CHD patients

CYP2C19 gene variants undermine clopidogrel stroke prevention

CYP2C19 gene variants undermine clopidogrel stroke prevention

Pre-procedural use of antiplatelet therapy becoming less routine in heart attack treatment

Pre-procedural use of antiplatelet therapy becoming less routine in heart attack treatment

Younger women more likely to experience one-year adverse cardiovascular events after PCI

Younger women more likely to experience one-year adverse cardiovascular events after PCI

UPMC uses simple gene test to personalize medications for patients undergoing heart catheterization

UPMC uses simple gene test to personalize medications for patients undergoing heart catheterization